Laboratorio Reig Jofre S.A. Logo

Laboratorio Reig Jofre S.A.

Develops and manufactures specialized pharmaceutical products and provides CDMO services.

RJF | MC

Overview

Corporate Details

ISIN(s):
ES0165359029
LEI:
9598003MRMJHA81QJF20
Country:
Spain
Address:
Gran Capità 10, 08970 Sant Joan Despí

Description

Laboratorio Reig Jofre is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products and food supplements. Founded in 1929, the company focuses on technologically specialized products, with expertise in injectable, freeze-dried (lyophilized), and topical formulations. Its portfolio includes essential medicines such as beta-lactam antibiotics. The company serves international markets and also provides contract development and manufacturing (CDMO) services to the pharmaceutical industry.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 11:36
Reig Jofre informa sobre el inicio del Scrip Dividend
Spanish 168.7 KB
2025-05-09 07:59
Reig Jofre remite las condiciones y el informe del Scrip Dividend
Spanish 454.9 KB
2025-05-09 07:48
Reig Jofre informa del cambio de Secretario no Consejero del Consejo de Adminis…
Spanish 150.2 KB
2025-05-09 07:44
Reig Jofre remite nota de prensa sobre los resultados del primer trimestre de 2…
Spanish 528.9 KB
2025-05-09 07:43
Reig Jofre presenta los resultados del primer trimestre de 2025
Spanish 4.6 MB
2025-05-08 19:43
Reig Jofre remite nota de prensa sobre la subvención obtenida del CDTi para imp…
Spanish 476.0 KB
2025-04-09 18:17
Reig Jofre remite los acuerdos adoptados en la Junta General de Accionistas de …
Spanish 160.4 KB
2025-04-04 01:28
Reig Jofre informa de las operaciones realizadas durante el primer trimestre de…
English 705.9 KB
2025-03-07 09:54
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 09:54
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 00:00
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-02-28 14:18
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 177.5 KB
2025-02-28 14:15
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 386.7 KB
2025-02-28 07:33
Reig Jofre remite nota de prensa sobre los resultados de 2024
Spanish 867.1 KB
2025-02-28 07:31
Reig Jofre presenta los resultados de 2024
Spanish 1.9 MB

Automate Your Workflow. Get a real-time feed of all Laboratorio Reig Jofre S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Reig Jofre S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Reig Jofre S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.